Muscle invasive bladder cancer (MIBC) is a widespread malignancy with a worse prognosis
often related to a late diagnosis. For early-stage MIBC pts, a multidisciplinary approach is …

Bladder cancer (BC) is the most common cancer of the urinary tract in the United States.
Imaging plays a significant role in the management of patients with BC, including the …

Objectives To evaluate accuracy and inter-observer variability using Vesical Imaging-
Reporting and Data System (VI-RADS) for discrimination between non-muscle invasive …

Objective To assess diagnostic validity and reliability of VI-RADS in predicting muscle
invasion by bladder cancer (BCa) and evaluate reviewer acceptance of VI-RADS for clinical …

The evolution in imaging has had an increasing role in the diagnosis, staging and follow up
of bladder cancer. Conventional cystoscopy is crucial in the diagnosis of bladder cancer …

Pelvic masses can present a diagnostic challenge owing to the difficulty in assessing their
origin and the overlap in imaging features. The majority of pelvic tumors arise from …

Bladder cancer is the ninth most common cancer, expected to lead to an estimated 17,670
deaths in the United States in 2019. Clinical management and prognosis of bladder cancer …

Bladder cancer (BC) is the 10th most common cancer worldwide. Approximately one quarter
of patients with BC have muscle-invasive disease (MIBC). Muscle-invasive disease carries a …

Despite its name, prostate-specific membrane antigen (PSMA) has been shown using
immunohistochemistry (IHC) to also be over-expressed in the tumor neovasculature of a …

While many institutions perform MRI during the work‐up of urinary bladder cancer, others
use MRI rarely if at all, possibly due to a variation in the reported staging accuracy and …